NCT04945226Phase 1/2Completed
A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
A Randomized, Open-Label, Exploratory, Pharmacokinetic, Sequential Single Ascending Dose Study of IVL3001 Versus Propecia (Finasteride) Tablets in Healthy Adult Participants
In the register
The register attaches this trial to IVL3001 (Inventage Lab), currently at “Phase 1/2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 1/2
- Sponsor
- Inventage Lab., Inc.
- Participants (registry)
- 40
- Start
- September 2021
- Primary completion
- February 2022
- Study completion
- February 2022
- Last registry update
- March 2022
- Countries
- Australia
Conditions studied: Androgenetic Alopecia
Interventions: Finasteride 1mg Tablet, IVL3001
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.